Medical Developments International reported AUD5.56M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Clinuvel Pharmaceuticals AUD 17.85M 9.36M Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Genetic Signatures AUD 4.78M 680K Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
Medical Developments International AUD 5.56M 2.26M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Paradigm Biopharmaceuticals AUD 16.6M 13.37M Dec/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Starpharma Holdings AUD 4.61M 614K Dec/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025